Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L24 pseudogene 7 (RPL24P7) is a processed pseudogene found in the human genome, specifically on chromosome 3[8]. It is a non-coding DNA sequence derived from the ribosomal protein L24 gene but lacks the ability to encode a functional protein due to accumulated mutations or deletions. This pseudogene has no established biological function, disease associations, or therapeutic relevance. Pseudogenes like RPL24P7 are typical in the human genome, often resulting from gene duplication or retrotransposition events, and generally do not produce functional protein products[8][7]. There are no reported interactions with drugs, no disease roles, no known biomarkers, and no safety concerns regarding RPL24P7. Its significance is limited to genomic annotation rather than functional or therapeutic utility[8][7].
None. No mechanism of action is available as it is not a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L24 pseudogene 7 (RPL24P7).